Placebo Saline Infusion
Placebo Saline Infusion is an intervention with 5 clinical trials. Currently 4 active trials ongoing. Historical success rate of 100.0%.
Success Metrics
Based on 1 completed trials
Phase Distribution
Phase Distribution
0
Early Stage
4
Mid Stage
0
Late Stage
Highest Phase Reached
Phase 2Trial Status & Enrollment
100.0%
1 of 1 finished
0.0%
0 ended early
4
trials recruiting
5
all time
Detailed Status
Development Timeline
Analytics
Development Status
Trials by Phase
Trials by Status
Recent Activity
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Ketamine for the Treatment of Depression in Parkinson's Disease
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
The Role of Amylin in Bone Metabolism
Clinical Trials (5)
Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure
Trial Investigating Visugromab and Nivolumab With or Without Docetaxel in 2L Treatment of Participants With Metastatic NSCLC
Ketamine for the Treatment of Depression in Parkinson's Disease
A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM
The Role of Amylin in Bone Metabolism
All 5 trials loaded
Drug Details
- Intervention Type
- OTHER
- Total Trials
- 5